Targeting <i>de novo</i> lipogenesis improves gemcitabine efficacy in pancreatic ductal adenocarcinoma
Sarah E. Hancock(Victor Chang Cardiac Research Institute), Nigel Turner(Garvan Institute of Medical Research)
Cited by 1
Related Papers
The Ratio of Macronutrients, Not Caloric Intake, Dictates Cardiometabolic Health, Aging, and Longevity in Ad Libitum-Fed Mice
|Cell Metabolism|2014|922
Insulin resistance is a cellular antioxidant defense mechanism
|Proceedings of the National Academy of Sciences|2009|541
Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I
|Diabetes|2008|527
Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle
|Diabetes|2007|515
Mitochondrial dysfunction and insulin resistance: an update
|Endocrine Connections|2014|506